Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early ...
A Randomized, Placebo-controlled, Parallel Group, Patient-blind, Phase I Study Assessing the Safety and Exploring the Immunogenicity/Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early Multiple System Atrophy A Randomized, Placebo-controlled, Parallel Group, Patient-blind, Phase I Study Assessing the Safety ...
Multiple System Atrophy;Neurodegenerative Diseases
Biological: AFFITOPE® PD01A + Adjuvant;Biological: AFFITOPE® PD03A + Adjuvant;Biological: Adjuvant without active component Biological: AFFITOPE® PD01A + Adjuvant;Biological: AFFITOPE® PD03A + Adjuvant;Biological: Adjuvant w ...
Affiris AG
University Hospital, Bordeaux;Institut National de la Santé Et de la Recherche Médicale, France;Forschungszentrum Juelich;University Hospital, Toulouse University Hospital, Bordeaux;Institut National de la Santé Et de la Recherche Médicale, France;Fors ...